Annual EBITDA
$1.09B$194.00M-15.17%
Summary
- Current Value
- As of today, HOLX annual EBITDA is $1.09B, down -15.17% on
- Historical Performance
- HOLX annual EBITDA is down -47.78% over the past 3 years, and down -28.91% over the past 5 years
- All-Time High Comparison
- HOLX annual EBITDA is currently -62.45% below its historical high of $2.89B set on
- 3-Year Low Comparison
- HOLX annual EBITDA is at its 3-year low
- Sector Comparison
- HOLX annual EBITDA is higher than 93.97% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.09B | -15.2% | -47.8% | -28.9% | +80.9% | |
| Quarterly EBITDA | $322.70M | +3.8% | +13.2% | -56.3% | +112.7% | |
| TTM EBITDA | $1.26B | -1.6% | -39.2% | -17.5% | +109.9% | |
| Price | $74.98 | +7.2% | -6.2% | -1.5% | +291.1% | |
| PE Ratio | 30.20 | +36.4% | +48.1% | +109.3% | – | |
| Annual Revenue | $4.10B | +1.7% | -15.7% | +8.6% | +144.1% | |
| Annual EPS | $2.49 | -25.2% | -51.5% | -41.0% | +1123.8% | |
| Annual EBIT | $785.40M | -19.1% | -52.4% | -31.7% | +157.4% | |
| Annual Net Income | $565.70M | -28.4% | -56.5% | -49.1% | +1000.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.08B | N/A | -47.8% |
| 5Y | $2.89B | -62.5% | |
| All | $2.89B | -62.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.09B | at low | |
| 5Y | $1.09B | at low | |
| All | -$22.94M | +4830.8% |
EBITDA History
FAQ
What is the current annual EBITDA of HOLX?
As of today, HOLX annual EBITDA is $1.09B
What is 1-year change in HOLX annual EBITDA?
HOLX annual EBITDA is down -15.17% year-over-year
What is 3-year change in HOLX annual EBITDA?
HOLX annual EBITDA is down -47.78% over the past 3 years
How far is HOLX annual EBITDA from its all-time high?
HOLX annual EBITDA is currently -62.45% below its historical high of $2.89B set on September 25, 2021
How does HOLX annual EBITDA rank versus sector peers?
HOLX annual EBITDA is higher than 93.97% of companies in Healthcare sector
When is HOLX next annual earnings release?
As of today, the next annual earnings release for HOLX has not been scheduled
Quarterly EBITDA
$322.70M$8.40M-2.54%
Summary
- Current Value
- As of today, HOLX quarterly EBITDA is $322.70M, down -2.54% on
- Historical Performance
- HOLX quarterly EBITDA is up +3.83% year-over-year, and up +13.23% over the past 3 years
- All-Time High Comparison
- HOLX quarterly EBITDA is currently -67.22% below its historical high of $984.30M set on
- 3-Year Low Comparison
- HOLX quarterly EBITDA is +22.10% above its 3-year low of $264.30M reached on
- Sector Comparison
- HOLX quarterly EBITDA is higher than 93.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $322.70M | -2.5% | +3.8% | +13.2% | -56.3% | |
| Annual EBITDA | $1.09B | – | -15.2% | -47.8% | -28.9% | |
| TTM EBITDA | $1.26B | +0.9% | -1.6% | -39.2% | -17.5% | |
| Price | $74.98 | +9.5% | +7.2% | -6.2% | -1.5% | |
| PE Ratio | 30.20 | +9.5% | +36.4% | +48.1% | +109.3% | |
| Quarterly Revenue | $1.05B | +2.5% | +6.2% | +10.1% | -22.1% | |
| Quarterly EPS | $0.83 | -4.0% | +9.6% | +76.5% | -55.9% | |
| Quarterly EBIT | $253.00M | -3.0% | +7.1% | +41.8% | -60.7% | |
| Quarterly Net Income | $187.30M | -3.9% | +4.9% | +57.8% | -62.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $331.10M | -2.5% | |
| 3Y | $349.40M | N/A | -7.6% |
| 5Y | $984.30M | N/A | -67.2% |
| All | $984.30M | -67.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $297.40M | +8.5% | |
| 3Y | $264.30M | +22.1% | |
| 5Y | $264.30M | +22.1% | |
| All | -$12.40M | +2702.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of HOLX?
As of today, HOLX quarterly EBITDA is $322.70M
What is HOLX quarterly EBITDA most recent change?
HOLX quarterly EBITDA was down -2.54% on September 27, 2025
What is 1-year change in HOLX quarterly EBITDA?
HOLX quarterly EBITDA is up +3.83% year-over-year
How far is HOLX quarterly EBITDA from its all-time high?
HOLX quarterly EBITDA is currently -67.22% below its historical high of $984.30M set on December 26, 2020
How does HOLX quarterly EBITDA rank versus sector peers?
HOLX quarterly EBITDA is higher than 93.67% of companies in Healthcare sector
When is HOLX next earnings release?
The next earnings release for HOLX is on
TTM EBITDA
$1.26B$11.90M+0.95%
Summary
- Current Value
- As of today, HOLX TTM EBITDA is $1.26B, up +0.95% on
- Historical Performance
- HOLX TTM EBITDA is down -1.58% year-over-year, and down -39.16% over the past 3 years
- All-Time High Comparison
- HOLX TTM EBITDA is currently -58.91% below its historical high of $3.06B set on
- 3-Year Low Comparison
- HOLX TTM EBITDA is +4.49% above its 3-year low of $1.20B reached on
- Sector Comparison
- HOLX TTM EBITDA is higher than 93.94% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.26B | +0.9% | -1.6% | -39.2% | -17.5% | |
| Annual EBITDA | $1.09B | – | -15.2% | -47.8% | -28.9% | |
| Quarterly EBITDA | $322.70M | -2.5% | +3.8% | +13.2% | -56.3% | |
| Price | $74.98 | +9.5% | +7.2% | -6.2% | -1.5% | |
| PE Ratio | 30.20 | +9.5% | +36.4% | +48.1% | +109.3% | |
| TTM Revenue | $4.10B | +1.5% | +1.7% | -15.7% | +8.6% | |
| TTM EPS | $2.48 | +3.0% | -25.2% | -51.5% | -40.9% | |
| TTM EBIT | $968.90M | +1.8% | -0.1% | -40.9% | -15.8% | |
| TTM Net Income | $565.80M | +1.6% | -28.3% | -56.5% | -49.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.27B | N/A | -1.0% |
| 3Y | $1.67B | N/A | -24.8% |
| 5Y | $3.06B | -58.9% | |
| All | $3.06B | -58.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.25B | +0.9% | |
| 3Y | $1.20B | +4.5% | |
| 5Y | $1.20B | +4.5% | |
| All | -$24.55M | +5228.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of HOLX?
As of today, HOLX TTM EBITDA is $1.26B
What is HOLX TTM EBITDA most recent change?
HOLX TTM EBITDA was up +0.95% on September 27, 2025
What is 1-year change in HOLX TTM EBITDA?
HOLX TTM EBITDA is down -1.58% year-over-year
How far is HOLX TTM EBITDA from its all-time high?
HOLX TTM EBITDA is currently -58.91% below its historical high of $3.06B set on June 26, 2021
How does HOLX TTM EBITDA rank versus sector peers?
HOLX TTM EBITDA is higher than 93.94% of companies in Healthcare sector
When is HOLX next earnings release?
The next earnings release for HOLX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- HOLX Official Website www.hologic.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/859737/000119312525244423/0001193125-25-244423-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/859737/000119312525244423/0001193125-25-244423-index.htm
- HOLX Profile on Yahoo Finance finance.yahoo.com/quote/HOLX
- HOLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/holx